Efficacy of High Doses Penicillin V Versus High Doses Amoxicillin in the Treatment of Non-severe Pneumonia.
NCT03208361 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 43
Last updated 2017-07-05
Summary
This study aims to evaluate wether high-dose penicillin V is as effective as high-dose amoxicillin for the treatment of non-sever community-acquired pneumonia (CAP).
Conditions
- Community-acquired Pneumonia (CAP)
Interventions
- DRUG
-
Penicillin V
- DRUG
-
Amoxicillin
Sponsors & Collaborators
-
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
lead OTHER
Principal Investigators
-
Car Llor Vilà, MD, PhD · IDIAP JORDI GOL
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-11-05
- Primary Completion
- 2016-03-29
- Completion
- 2016-04-21
Countries
- Spain
Study Locations
More Related Trials
-
Pharmacokinetics, Safety and Efficacy of POL7080 in Patients With Ventilator Associated Pseudomonas Aeruginosa Pneumonia
NCT02096328 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin in Hospitalized Patients With Non-severe Community-acquired Pneumonia
NCT00887276 ·Status: TERMINATED ·Phase: PHASE4
-
The Study Of Azithromycin Switch Therapy For Treatment Of Community Acquired Pneumonia (CAP)
NCT00809328 ·Status: COMPLETED ·Phase: PHASE3
-
Reason Evaluation of Initial Treatment Failure in Patients With CAP
NCT03280004 ·Status: UNKNOWN
-
A Global Active Surveillance for Community Acquired Pneumonia
NCT00929721 ·Status: COMPLETED ·Phase: NA
-
Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward
NCT06229288 ·Status: RECRUITING ·Phase: PHASE3
-
The Norwegian Antibiotics for Pneumonia in Children Study
NCT03446534 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Efficacy of Amoxicillin Given Twice or Three Times a Day Among Children With Non-severe Pneumonia
NCT01200706 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia
NCT00270517 ·Status: UNKNOWN ·Phase: PHASE2
-
Usefulness of Microbiological Tests in Community-Acquired Pneumonia
NCT00312741 ·Status: UNKNOWN
-
Study on Costs and Safety of Early Conversion From Intravenous to Oral Antibiotic Treatment in Patients With Severe Community-Acquired Pneumonia
NCT00273676 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial for the Assessment of Delayed Antibiotic Treatment Strategies
NCT01363531 ·Status: COMPLETED ·Phase: PHASE4
-
Telithromycin, Treating Adult Outpatients With Mild to Moderate Community-acquired Pneumonia (CAP) in High Bacterial Resistance Areas
NCT00538018 ·Status: COMPLETED ·Phase: PHASE4
-
Optimizing Care for Children Hospitalized With Community-acquired Pneumonia: Short-course Therapy
NCT06125340 ·Status: RECRUITING ·Phase: PHASE4
-
Amoxicillin/Clavulanic Acid Susceptibility in Acute Community-acquired Pneumonia Requiring Intensive Care Management
NCT07322549 ·Status: COMPLETED
-
Efficacy and Safety of Jaktinib in Participants With Severe Novel Coronavirus Pneumonia(COVID-19)
NCT05702788 ·Status: WITHDRAWN ·Phase: PHASE2
-
Comparison Between Amoxycillin/Clavulanic Acid and Oxacillin/Ceftriaxone for Community Acquired-pneumonia
NCT01166932 ·Status: COMPLETED ·Phase: PHASE4
-
Short Duration Treatment of Non-severe Community Acquired Pneumonia
NCT01963442 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP
NCT07327619 ·Status: RECRUITING ·Phase: PHASE3
-
Adequate Duration of Antibiotic Treatment in Community-acquired Pneumonia With High Risk Class and Adequate Initial Clinical Response
NCT03609099 ·Status: UNKNOWN ·Phase: PHASE4
-
Procalcitonin to Reduce Antibiotic Use in Pediatric Pneumonia
NCT04963764 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia
NCT04724044 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Demonstrate the Clinical Efficacy of Levofloxacin in the Treatment of Pneumonia
NCT00253955 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of BT086 to Evaluate Adjunctive Therapy in sCAP
NCT01420744 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing Effectiveness of Community Acquired Pneumonia Treatment by Continuous Pneumonia Severity Score
NCT04135183 ·Status: UNKNOWN ·Phase: NA